Jennafer Dotson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Gabriele Schaefer1
Steve Sideris1
Shiva Malek1
1Gabriele Schaefer
1Steve Sideris
1Shiva Malek
1Daniel J. Burdick
Learn More
Activating mutations within the epidermal growth factor receptor (EGFR) kinase domain, commonly L858R or deletions within exon 19, increase EGFR-driven cell proliferation and survival and are correlated with impressive responses to the EGFR inhibitors erlotinib and gefitinib in nonsmall cell lung cancer patients. Approximately 60% of acquired resistance to(More)
To minimize the risk of failure in clinical trials, drug discovery teams must propose active and selective clinical candidates with good physicochemical properties. An additional challenge is that today drug discovery is often conducted by teams at different geographical locations. To improve the collaborative decision making on which compounds to(More)
  • 1